IN SIX DAYS: Enjoy an audience with Gervais Williams (AND the cheapest stock on AIM) - book a free seat now
Synnovia (Plastics Capital as was) – trading statement; is a 10%+ forecast reduction really “broadly in line”?!
Published 27 days ago
How I suffer for you dear listeners. All is explained. Then there is a long discussion on the administration of Patisserie Holdings (CAKE). I move on with a few more words on The Escape Group (ESC) which I covered HERE and then look at Eve Sleep (EVE) and the folly of Neil Woodford, Scancell (SCLP), Anglesey Mining (AYM), Ariana (AAU), Bluebird Merchant Ventures (BMV), Chesterfield (CHF) and Metro Bank (MTRO). Finally it is one day to ouzo time (again) on Frontera Resources (FRR).
Published 75 days ago
I start with a few Greek ramblings, The Iliad and the Greek Hovel, going to a bank, etc. Then I look at the wider stockmarket woes and then onto TrakM8 (TRAK), Versarien (VRS), BlueJay (JAY), FinnCrap (FCAP) and the resigning analyst and finally I have grave questions about the statement made on November 15 by Neil Woodford dog Eve Sleep (EVE). Surely there must be a steward's?
Published 75 days ago
After spunking millions backing companies wanting to change the laws of physics or disrupt the markets for wooden pallets, washing machines and drinking water a chance to revolutionise the world of mattresses was just too good to pass up on for Neil Woodford. So he backed the May 2017 IPO of Eve Sleep (EVE) at 100p heavily and as the share price sank he added to his holding taking it to 29.05%. Neil always knows better than the market….
Published 96 days ago
I always thought that mattresses were all about getting a good night’s sleep. Thank goodness I didn’t follow Neil Woodford into (now) AIM-listed Eve Sleep, paying up to 150p a share for 30% of the business and now facing another cash call with the shares down at just 15p!
Published 96 days ago
In today's bearcast I clarify why I believe Mrs May's Brexit deal sucks and should be binned. But what happens next? I outline a few possibilities but admit I have not got a scoobie. I then look at Neil Woodford dog Eve Sleep (EVE) and again at UK Oil & Gas (UKOG) after today's disastrous news.
Published 184 days ago
Turning to my third, and the most recent, quoted constituent of Woodford Patient Capital Trust (WPCT) this weekend, I thought I should give a warm welcome to Sensyne Health (SENS) that joined AIM on Friday at a very nice valuation indeed. It’s good to see that the words ‘healthtech’ and ‘AI’ are able to suck in as much dumb money from the markets these days as the word ‘blockchain’!
Published 185 days ago
Neil Woodford doesn’t have many quoted stocks in Woodford Patient Capital Trust (WPCT) but I thought I’d look at three classic picks this weekend, two of which I’ve touched on before, the third being a brand new entrant. I’ll start by catching up with the two Norwegian quoted companies in the portfolio – first up, Idex.
Published 232 days ago
As it happens I am in the process of buying a number of new mattresses for the house I have rebuilt in Greece. And it seems a remarkably simple process buying what is a commodity product. When my friend Nigel Wray says his mattress company Simba is revolutionising the market I cough and change the subject. But he is not the only one who thinks that mattresses need “disrupting”. Natch, Neil Woodford, the UK's most conceited fund manager, also thinks that, like washing machines mattresses, are ripe for a revolution. He owns just under 30% of Eve Sleep (EVE) shares of which are now in free fall.
Published 445 days ago
A week ago, I noted that news was due from the disruptive pallet manufacturer, RM2 International (RM2) and doubted that it was going to be positive. Well, it finally came out yesterday and I wasn’t disappointed although assume Neil Woodford and the long suffering shareholders of this and his Patient Capital Trust (WPCT) probably were.
Published 523 days ago
I covered the trading update for the Woodford-backed Eve Sleep (EVE) HERE but with interims out this week, it is worth taking a closer look to assess progress in its maiden year on AIM. In summary, I would give it a B+ grade for execution but only a D grade for “ability to show there is a viable business model here” and would keep a watching brief for now. Doesn’t stop Neil Woodford getting stuck In some more though – natch
Published 587 days ago
Following my initial piece on the Woodford-backed Eve Sleep (EVE) two weeks ago, I thought I would comment on today’s trading update which outlined great growth but it’s what it doesn’t say that worries me a tad.
Published 597 days ago
Thought I’d write a few sleep-related pieces today and am starting with initiating coverage on the mattress e-tailer, Eve Sleep (EVE). The company joined AIM in May raising £35 million and there is a lot to like about the business, but is it really worth over £130 million?